Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 39

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 39
---
 addition, we have agreed to pay Placement Agent the following compensation in connection with any future exercise of the Private Placement Warrants issued in the concurrent private placement: (i) a cash fee equal to 7.5% of the aggregate gross exercise price paid in cash with respect to the exercise of the Private Placement Warrants; and (ii) a management fee equal to 1.0% of the aggregate gross exercise price paid in cash with respect to the exercise of the Private Placement Warrants and issue to the Private Placement (or its designees) warrants to purchase shares of our common stock representing 7.5% of the shares of common stock underlying the Private Placement Warrants that have been exercised.

<div align='center'>S-25</div>

From the date hereof until five days after the after the closing of this offering, subject to certain exceptions, we may not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement thereto, other than a prospectus supplement for the registration statement of which this prospectus supplement forms a part. In addition, from the date of this prospectus supplement until one (1) year after the closing of this offering, we are prohibited from effecting or entering into an agreement to effect any issuance of Common Stock or Common Stock equivalents involving a variable rate transaction, subject to certain exception.

Certain Relationships

The Placement Agent and its affiliates have and may in the future provide, from time to time, investment banking and financial advisory services to us in the ordinary course of business, for which they may receive customary fees and commissions. The Placement Agent acted as our placement agent in connection with the private placement we consummated in September 2024, for which it received compensation. However, except as disclosed in this prospectus, we have no present arrangements with Wainwright for any further services.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Equity Stock Transfer, LLCwhose address is 237 West 37th Street, Suite 602, New York, NY 10018 and telephone number is (212) 575-5757

Listing

Our common stock is listed on The Nasdaq Capital Market under the symbol “SXTP.” On January 28, 2025, the last reported sale price of our common stock on The Nasdaq Capital Market was $0.771.

<div align='center'>S-26

PRIVATE PLACEMENT